We are live on ! Find out more
DYN icon

Dyne Therapeutics
DYN

118 hedge funds and large institutions have $666M invested in Dyne Therapeutics in 2023 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 57 increasing their positions, 28 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

104% more repeat investments, than reductions

Existing positions increased: 57 | Existing positions reduced: 28

6% more capital invested

Capital invested by funds: $629M → $666M (+$37.1M)

4.55% more ownership

Funds ownership: 96.96% → 101.51% (+4.5%)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

7% less funds holding

Funds holding: 127 → 118 (-9)

38% less first-time investments, than exits

New positions opened: 15 | Existing positions closed: 24

74% less call options, than puts

Call options by funds: $46K | Put options by funds: $179K

Holders
118
Holders Change
-9
Holders Change %
-7.09%
% of All Funds
1.85%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
15
Increased
57
Reduced
28
Closed
24
Calls
$46K
Puts
$179K
Net Calls
-$133K
Net Calls Change
-$304K

Top Buyers

1
VA
VR Adviser
New York
+$25.6M
2
State Street
State Street
Massachusetts
+$13.9M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$11.1M
4
AC
Armistice Capital
New York
+$10.8M
5
BlackRock
BlackRock
New York
+$8.29M

Top Sellers

1
EC
EcoR1 Capital
California
-$18M
2
WA
Wasatch Advisors
Utah
-$7.88M
3
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$5.9M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
-$5.81M
5
HA
HHLR Advisors
Cayman Islands
-$5.51M
Name Holding Trade Value Shares
Change 		Change in
Stake
CANY
126
Caxton Associates (New York)
New York
– -$432K -37,501 Closed
Jane Street
127
Jane Street
New York
– -$318K -27,629 Closed
CSS
128
Cubist Systematic Strategies
Connecticut
– -$314K -27,240 Closed
JF
129
Jump Financial
Illinois
– -$277K -24,064 Closed
D.E. Shaw & Co
130
D.E. Shaw & Co
New York
– -$273K -23,668 Closed
Connor, Clark & Lunn Investment Management (CC&L)
131
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
– -$242K -21,010 Closed
TD Asset Management
132
TD Asset Management
Ontario, Canada
– -$241K -20,900 Closed
Qube Research & Technologies (QRT)
133
Qube Research & Technologies (QRT)
United Kingdom
– -$204K -17,726 Closed
OCM
134
Ovata Capital Management
Hong Kong
– -$173K -15,000 Closed
SO
135
STRS Ohio
Ohio
– -$152K -13,200 Closed
SG Americas Securities
136
SG Americas Securities
New York
– -$129K -11,183 Closed
XT
137
XTX Topco
Cayman Islands
– -$122K -10,629 Closed
MAM
138
Martingale Asset Management
Massachusetts
– -$120K -10,441 Closed
BCM
139
Bridgeway Capital Management
Texas
– -$120K -10,400 Closed
DWA
140
Dorsey Wright & Associates
California
– -$18K -1,559 Closed
TWA
141
TCI Wealth Advisors
Arizona
– -$8.54K -741 Closed
2 3 4 5
6

DYN Hedge Fund Activity: Q2 2023 in Review

118 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Dyne Therapeutics (DYN) for Q2 2023, worth a combined $666M — up 5.9% from $629M a quarter earlier.

Sellers outnumbered buyers: 24 funds closed out of DYN and 15 opened new positions — a net loss of 9 holders — while 28 trimmed existing stakes and 57 added.

The largest buyer was VR Adviser, opening a new position worth an estimated $25.6M. The largest seller was EcoR1 Capital, cutting an estimated $18M.

  • 118 institutional investors held Dyne Therapeutics (DYN) as of Q2 2023, down from 127 in Q1 2023.
  • Funds reported $666M of Dyne Therapeutics stock for Q2 2023, up 5.9% quarter-over-quarter.
  • 15 funds opened new Dyne Therapeutics positions in Q2 2023 and 24 closed out, a net change of -9 holders.
  • The largest Dyne Therapeutics buyer in Q2 2023 was VR Adviser, an estimated $25.6M added.
  • The largest Dyne Therapeutics seller in Q2 2023 was EcoR1 Capital, an estimated $18M sold.

Based on aggregated 13F filings for Q2 2023.